Avance Biosciences

Analytical and Bioanalytical Solutions - Empowering Drug Development and Manufacturing

[Avance Biosciences @AvanceBio]

The FDA has released three new draft guidances designed to accelerate and strengthen the development of cell and gene therapies, marking a significant step forward for the field. https://t.co/qKhHaIuRUU

[Avance Biosciences @AvanceBio]

Avance Biosciences offers CGMP- and GLP-compliant assay development, validation, and sample testing for biopharma. Visit our booth #2934 to explore how we support drug development and manufacturing with precision and expertise. https://t.co/xDWolLsT6o

[Avance Biosciences @AvanceBio]

Avance Biosciences’ NGS Center of Excellence delivers comprehensive sequencing solutions, including short-read, long-read, and advanced single-cell platforms. Our regulatory-compliant workflows support biologics, gene, and cell therapy programs with... https://t.co/RpWdXUcjwV

[Avance Biosciences @AvanceBio]

Avance Biosciences is heading to the BioProcessing Summit next week! Booth #516
https://t.co/kty7IzBcJP

[Avance Biosciences @AvanceBio]

To support IND-enabling studies, a biotech company needed precise measurement of in vivo gene-editing efficiency in preclinical rat tissues. Avance Biosciences delivered a fully validated NGS amplicon sequencing assay capable of detecting edits as low... https://t.co/rRjgX8Lo6w

[Avance Biosciences @AvanceBio]

When a gene therapy company needed to verify plasmid identity, purity, and integrity for an IND submission, Avance Biosciences delivered a validated NGS-based solution. The assay enabled low-level variant detection and trace contaminant analysis... https://t.co/eLewqebNNw

[Avance Biosciences @AvanceBio]

Potency assays are critical for demonstrating the safety and efficacy of biologics, but developing them can be complex, especially for cell and gene therapies. Download our latest technote: Successful Development of Cell-based Potency Assays https://t.co/0yzEcjrkvy

[Avance Biosciences @AvanceBio]

Our new blog series explore how cutting-edge NGS technologies are being applied to solve real-world challenges in biopharmaceutical development. Follow along for insights into assay strategies, platform selection, and the measurable impact of our... https://t.co/qrgWgyhFuY

[Avance Biosciences @AvanceBio]

Avance Biosciences™ be presenting two posters as part of the Next-Gen Analytical Methods program: Genome-wide Mapping of CRISPR-Cas Off-Target Cleavage Sites via GUIDE-Seq & Digitally Secure Sequencing: Implementing Part 11-Ready NGS Data Security in... https://t.co/kty7IzBKzn

[Avance Biosciences @AvanceBio]

We’ve expanded our bioanalytical capabilities with powerful LC-MS/MS services to provide highly sensitive and accurate analytical solutions for drug development, biomarker discovery, and biologics characterization.
https://t.co/FY3z8kuS8b

[Avance Biosciences @AvanceBio]

We’re excited to share that Avance Biosciences™ will be exhibiting at the BioProcessing Summit 2025, taking place August 18–21 in Boston, MA. (Booth No. 516) https://t.co/8sPaFUjL7C

[Avance Biosciences @AvanceBio]

Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company’s sequencing capabilities across all phases of drug development. https://t.co/OaxBa9AOoy

[Avance Biosciences @AvanceBio]

Avance is growing to better support biopharmaceutical drug development and manufacturing. We are continuing to add new technologies and platforms to support our clients’ needs. https://t.co/aKPmUXk1c7

[Avance Biosciences @AvanceBio]

Avance Biosciences is excited to join WRIB 2025 in New Orleans, showcasing our expertise in bioanalytical testing for biologics and biosimilars. Visit us at Booth #78 to explore our advanced solutions, including LBA, Flow Cytometry, qPCR, and LC-MS/MS.https://t.co/1pILsvde4O

[Avance Biosciences @AvanceBio]

Avance fully embraced Halloween last Thursday with a costume contest, candy galore, and a pizza party. The day was filled with fun, warmth, and cheer as everyone shared in the festive spirit and made lasting memories together. https://t.co/ygz68FxXgi

[Avance Biosciences @AvanceBio]

Avance Biosciences is excited to announce its participation in the upcoming SITC Conference. This premier event is focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied #cancer #immunotherapy. https://t.co/KwwcNQN1YS

[Avance Biosciences @AvanceBio]

Avance Biosciences will be exhibiting at the AAPS PharmSci 360 meeting from October 15-18, 2024. Join us to explore our innovative biological assay development and testing services that can help you navigate drug development challenges. See you there! https://t.co/5dstqgYSvu

[Avance Biosciences @AvanceBio]

Avance Biosciences is excited to announce its participation in the upcoming Immunogenicity & Bioassay Summit, taking place from October 15 -18, 2024, in Washington DC. This is the #1 Immunogenicity & Bioassay Event in the U.S. https://t.co/VUuXLOuDoL

[Avance Biosciences @AvanceBio]

Our team will showcase our cutting-edge expertise in #geneediting analysis, focusing on on/off-target effects, which are crucial for the development of safe & effective #CRISPR-based therapies. Our comprehensive services include: GUIDE-Seq, rhAmpSeq™... https://t.co/KFbhsgRr1p

[Avance Biosciences @AvanceBio]

Avance Biosciences is heading to the 2nd CRISPR-Based Therapy Analytical Development Summit in Boston from September 17-19! Join us to explore our cutting-edge expertise in gene editing analysis, including GUIDE-Seq and rhAmpSeq™, and see how our... https://t.co/KFbhsgRr1p